Sygnis Pharma AG, which specialises in neurodegenerative diseases, has appointed Frank Rathgeb as its chief medical officer. He also will serve on the executive management board.
Dr Rathgeb was previously a vice president for pipeline management and strategic controlling at Altana Pharma AG.
Source:
Sygnis press release, 17 March 2008
Copyright 2008 Evernow Publishing Ltd